Join us at ASGCT 2024: May 7-11
Join us at ASGCT 2024 in Baltimore, MD from May 7-11, 2024! Meet us at booth #2388 and explore our 100% guaranteed service and learn…
Read more
Join Us at PEGS Boston 2024
PEGS Boston is taking place from May 13-17 at the Omni Hotel at the Seaport! Our team will be at Booth #23 and will…
Read more
Biocytogen Enters into Evaluation and Potential Licensing Agreement with BioCopy for TCR-mimic Antibodies
Beijing, China, May 6, 2024 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based…
Read more
May 2024 Newsletter
New Animal Models Humanized Immune-Checkpoint Mice Product Catalog Number B-hXCR1 mice 112815 B-h4-1BB, Tg(hLILRB1/hLILRB4) mice 112731 B-hCD3EDG/hCD19/hBCMA mice 113343 Humanized Cytokine Mice Product Catalog…
Read more
Join Us At Immunology 2024: May 3-7
Join us at Immunology 2024 in Chicago, IL from May 3-7! Meet our team at booth #530 and discover how our humanized models, disease models,…
Read more
Check Out Our CD40 mAb Phase II Poster at ASCO2024!
ASCO 2024 | Biocytogen/Eucure Biopharma to Present Two Phase II Clinical Studies of CD40 Agonistic Antibody YH003 Biocytogen’s wholly owned subsidiary Eucure Biopharma today…
Read more
Join us at Booth D23 at BIO KOREA 2024! May 8-10
Biocytogen’s APAC business development team is excited to exhibit and host 1-on-1 meetings at BIO KOREA 2024, taking place from May 8-10, 2024 in Seoul,…
Read more
Immuno-Oncology Summit Europe 2024: April 23-25
Visit Our Bispecific Antibody Poster at IO Summit Europe 2024! Biocytogen’s antibody Business Development & Licensing team is excited to attend the upcoming Immuno-Oncology…
Read more
Festival of Biologics USA 2024: April 15-17
Thank you to those who joined us at the Festival of Biologics USA 2024 from April 15-17 in San Diego, CA! Our Poster titled…
Read more
Biocytogen’s Antibody Partner Syncromune® Inc. Presents Positive Results from SYNC-T™ SV-102 Phase 1 Trial at AACR Annual Meeting 2024
On April 7, at AACR, our therapeutic antibody collaborator Syncromune delivered an oral presentation unveiling clinical data of its SYNC-T technology for the first time!…
Read more